News

ACXP
Acurx Pharmaceuticals, Inc. News

This news view pulls recent coverage and headlines tied to ACXP.

Latest Close

$2.09

1y Change

-$5.11 (-70.97%)

Market Cap

$5,967,002.00

Sector

Healthcare

Industry

Biotechnology

Recommendation

strong_buy

Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026

PR Newswire • May 4, 2026

Read article

Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

PR Newswire • Apr 29, 2026

Read article

Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit

TMX Newsfile • Apr 27, 2026

Read article

Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update

PR Newswire • Apr 20, 2026

Read article

New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics (NASDAQ:VVOS)

ACCESS Newswire • Apr 18, 2026

Read article

Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

PR Newswire • Apr 16, 2026

Read article